PTC Therapeutics
PTCT
#2687
Rank
ยฃ4.65 B
Marketcap
ยฃ57.99
Share price
-0.76%
Change (1 day)
52.88%
Change (1 year)

Operating Margin for PTC Therapeutics (PTCT)

Operating Margin as of December 2025 (TTM): 41.64%

According to PTC Therapeutics 's latest financial reports and stock price the company's current Operating Margin is 41.64%. At the end of 2024 the company had an Operating Margin of -24.31%.

Operating Margin history for PTC Therapeutics from 2012 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-24.31%-59.79%
2023-60.45%-14.94%
2022-71.07%-11.46%
2021-80.27%-11.81%
2020-91.02%22.86%
2019-74.09%69.73%
2018-43.65%31.98%
2017-33.07%-79.29%
2016-159.67%-64.87%
2015-454.58%15.44%
2014-393.79%200.96%
2013-130.85%40.47%
2012-93.15%-401.43%
201130.90%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Vertex Pharmaceuticals
VRTX
2.25%-94.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-10.44%-125.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-2,241.75%-5,483.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-2,634.59%-6,427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-82.45%-298.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
29.12%-30.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.